Contraindications and Precautions for Beta Blocker Use

Absolute Contraindications

• The American Heart Association recommends that beta blockers are contraindicated in patients with severe bradycardia with heart rate <45-50 bpm, particularly when symptomatic with dizziness, lightheadedness, or syncope 1, 2
• The American College of Cardiology states that second or third-degree AV block without a functioning permanent pacemaker is an absolute contraindication for beta blocker use 1
• Decompensated heart failure with signs of low output state, pulmonary congestion, S3 gallop, or oliguria is an absolute contraindication for beta blocker use, as recommended by the American Heart Association 1, 2
• Severe hypotension with systolic blood pressure <90-100 mmHg, especially when symptomatic, is an absolute contraindication for beta blocker use, according to the American College of Cardiology 1, 2
• Active bronchial asthma is an absolute contraindication, particularly with active bronchospasm, as stated by the European Society of Cardiology 1, 3

Relative Contraindications

• The European Heart Journal recommends that beta blockers are not contraindicated in patients with mild to moderate COPD (FEV1 >50% predicted) when cardioselective beta-1 selective agents are used 5
• The American College of Cardiology suggests that patients with heart failure and reduced ejection fraction (LVEF <40%) should receive beta blockers, providing a 30% mortality reduction, unless contraindicated 2, 4
• The European Society of Cardiology states that beta blockers are contraindicated only during acute decompensation of heart failure—once stabilized and euvolemic, beta blockers should be initiated at low doses and titrated gradually 1, 2, 3

Agent Selection and Common Pitfalls

• The American Heart Association recommends using only cardioselective beta-1 selective agents, such as bisoprolol, metoprolol succinate, or nebivolol, in patients with pulmonary disease 4, 5
• The European Heart Journal advises against withholding beta blockers from stable heart failure patients simply because they have COPD—the mortality benefit outweighs risks when cardioselective agents are used 4
• The American College of Cardiology warns against abruptly discontinuing beta blockers, as this can precipitate severe angina exacerbation, myocardial infarction, or ventricular arrhythmias 1